Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.
Artio Medical has raised $28.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Artio Medical's investors include National Institutes of Health, Serra Ventures, Mid-America Angels, Accelerate Venture Partners, Kansas Bioscience Authority.
Artio Medical is headquartered in Olathe, United States.
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.
Artio Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artio Medical — Funding & Investors." VCBacked, June 16, 2022, https://www.vcbacked.co/company/artio-medical. Accessed October 4, 2026.
VCBacked. (2022). Artio Medical — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/artio-medical
{{cite web |title=Artio Medical — Funding & Investors |url=https://www.vcbacked.co/company/artio-medical |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated